William E. Barlow, PhD
Senior Investigator
206-287-2936
barlow.w@ghc.org
Recent publications
Curriculum vitae (CV)
Research interests and experience
- Biostatistics: case-cohort analysis; assessment of diagnostic tests; survival analysis
- Cancer control: biostatistics; breast cancer screening and treatment; mammography; molecular markers
- Alternative approaches to healing: biostatistics; acupuncture efficacy
- Women's health: breast cancer
Bill Barlow is a biostatistician with interests in outcomes of breast cancer screening and treatment.
Recent publications
Taplin SH, Abraham L, Geller BM, Yankaskas BC, Buist DS, Smith-Bindman R, Lehman C, Weaver D, Carney PA, Barlow WE. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. J Natl Cancer Inst. 2010;102(14):1040-51. Epub 2010 Jul 2. PubMed
Sherman KJ, Cherkin DC, Ichikawa L, Avins AL, Delaney K, Barlow WE, Khalsa PS, Deyo RA. Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain. Spine. 2010 Jul 1;35(15):1471-7. Epub 2010 Jun 8. PubMed
Ichikawa LE, Barlow WE, Anderson ML, Taplin SH, Geller BM, Brenner RJ. Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004. Radiology. 2010 Jul;256(1):74-82. Epub 2010 May 26. PubMed
Spangler L, Reid RJ, Inge R, Newton KM, Hujoel P, Chaudhari M, Genco RJ, Barlow WE. Cross-sectional study of periodontal care and glycosylated hemoglobin in an insured population. Diabetes Care. 2010 Aug;33(8):1753-8. Epub 2010 May 26. PubMed
Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DS. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1643-54. Epub 2010 May 25. PubMed
Steinwachs D, Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, Keating NL, Kim P, Lave JR, Laveist TA, Ness RB, Optican RJ, Virnig BA. National Institutes of Health State-of-the-Science conference statement: enhancing use and quality of colorectal cancer screening. Ann Intern Med. 2010 May 18;152(10):663-7. Epub 2010 Apr 13. PubMed
Yao S, Barlow WE, Albain KS, Choi JY, Zhao H, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Kent Osborne C, Abeloff MD, Hortobagyi GN, Hayes DF, Ambrosone CB. Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer. Breast Cancer Res Treat. 2010 Mar 23. [Epub ahead of print]. PubMed
Harigopal M, Barlow WE, Tedeschi G, Porter PL, Yeh IT, Haskell C, Livingston R, Hortobagyi GN, Sledge G, Shapiro C, Ingle JN, Rimm DL, Hayes DF. Multiplexed assessment of the Southwest Oncology Group-directed intergroup breast cancer trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome. Am J Pathol. 2010;176(4):1639-47. Epub 2010 Feb 11. PubMed
Morris DE, Pepe MS, Barlow WE. Contrasting two frameworks for ROC analysis of ordinal ratings. Med Decis Making. 2010 Feb 10. [Epub ahead of print]. PubMed
Allen JD, Barlow WE, Duncan RP, Egede LE, Friedman LS, Keating NL, Kim P, Lave JR, Laveist TA, Ness RB, Optican RJ, Steinwachs D, Virnig BA. NIH State-of-the-Science Conference statement: enhancing use and quality of colorectal cancer screening. NIH Consens State Sci Statements. 2010;27(1). PubMed
To view more publications, please see Dr. Barlow's CV.